1st Quarter - Report — HUMANA, INC. for HUMANA INC (2018)

Firm

HUMANA, INC.

Client

HUMANA INC

Income

—

Expenses

$260,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Tricare Issues H.R. 2810/S. 1519, FY 2018 National Defense Authorization Act Implementation

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: White House Office; Health & Human Services, Dept of (HHS); Treasury, Dept of; SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2810 (115th), S. 1519 (115th)

Taxation/Internal Revenue Code TAX

H.R. 1370, Continuing Appropriations through January 19, 2018 H.R. 195, Extension of Continuing Appropriations Act of 2018 H.R. 246, Jobs and Premium Protection Act H.R. 4620, Protecting Families and Small Business Act S. 1859, Healthcare Tax Relief Act S. 1978, Small Business and Family Health Tax Relief Act

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DEBRA OBERMAN	—
DOUGLAS STOSS	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Treasury, Dept of; SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: S. 1978 (115th), S. 1859 (115th), H.R. 1370 (115th), H.R. 195 (115th), H.R. 246 (115th), H.R. 4620 (115th)

Health Issues HCR

Bipartisan Healthcare Stabilization Act (Alexander-Murray) Affordable Care Act Implementation H.R. 2026 Pharmaceutical Information Exchange Act H.R. 878, H.R. 2368, S. 204 Right-to-Try Legislation

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DEBRA OBERMAN	—
DOUGLAS STOSS	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2368 (115th), S. 204 (115th), H.R. 2026 (115th), H.R. 878 (115th)

Medicare/Medicaid MMM

Medicare Advantage Policy and Reimbursement Part D Policy and Reimbursement Medicaid and Dual Eligible Issues Pharmacy Reimbursement Issues Medicare Access and CHIP Reauthorization Act Implementation Opioid Issues H.R. 1892, Bipartisan Budget Act of 2018 H.R. 1625, Consolidated Appropriations Act of 2018 S. 637, Creating Transparency to Have Drug Rebates Unlocked Act S. 870, Creating High Quality Results and Outcomes Necessary to Improve Chronic Care Act H.R. 3727, Medicare Advantage Telehealth bill H.R. 3168, Medicare Advantage Special Needs Plans Reauthorization H.R. 3528, Every Prescription Conveyed Securely Act

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DEBRA OBERMAN	—
DOUGLAS STOSS	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; White House Office; Treasury, Dept of

Bills named: H.R. 1892 (115th), H.R. 3528 (115th), H.R. 3168 (115th), H.R. 3727 (115th), S. 870 (115th), S. 637 (115th), H.R. 1625 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.